Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Nephrology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Nephrology Other
    Heart Failure Patients With Kidney Dysfunction Fare Poorly After Hospital Discharge: Presented at AHA - (DGDispatch)
    Atorvastatin Improves Renal Function in Patients With Heart Disease, Metabolic Syndrome: Presented at AHA - (DGDispatch)
    Darbepoetin Alfa Risky for Type 2 Diabetics With Kidney Disease: Presented at AHA - (DGDispatch)
    Revascularization versus Medical Therapy for Renal-Artery Stenosis - (N Engl J Med)
    High Blood Pressure In Children With Kidney Disease Often Missed - (DGNews)

    News archive

     Recent webcasts/CME - Nephrology Other
    • Improving Long-Term Outcomes in Kidney Transplant Recipients: A Case-Based Approach to the Prevention and Management of Post-Transplant Morbidity
    • Managing Post-Transplant Complications in a 62-Year-Old Woman
    • Improving Graft Dysfunction in a 56-Year-Old Man With Multiple Comorbidities
    • Expanding Options for First-Line Treatment of Advanced Kidney Cancer: How Can We Choose the Right Treatment for the Right Patient?
    • Diabetes and the Heart: Cardiometabolic Screening and Hospital Care

      Webcasts/CME archive

       Recent cases - Nephrology Other
        Polycythemia Vera as a Presentation of Renal Angiomyolipoma: A Case Report
        Successful Use of Single-Dose Rituximab for the Maintenance of Remission in a Patient with Steroid-Resistant Nephrotic Syndrome
        A 78-Year-Old Woman with Proton Pump Inhibitor-Induced Acute Interstitial Nephritis
        Renal Amyloidosis in Whipple Disease: A Case Report
        Atypical Imaging Findings in a Renal Transplant Patient with Reversible Posterior Leukoencephalopathy Syndrome: A Case Report

        Cases archive
          




        my personal edition > nephrology other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Calcineurin Inhibitor Sparing Using Mycophenolate May Play a Key Role in Kidney Transplantation: Presented at ASN

        By Maggie Schwarz

        PHILADELPHIA -- November 9, 2008 -- Adjunctive mycophenolate used in a calcineurin inhibitor-sparing strategy may play an important role in kidney transplant recipients, according to research presented at Renal Week 2008, the American Society of Nephrology (ASN) annual meeting.

        Coinvestigator Keith Wheatley, MD, University of Birmingham, Birmingham, United Kingdom, was part of a team that performed a systematic review and meta-analysis of 19 randomized controlled trials in which calcineurin inhibitor sparing was accompanied by continuation of mycophenolate or conversion to this agent and compared with standard or higher-dose calcineurin inhibitor therapy. Dr. Wheatley reported the results here at a poster presentation on November 8.

        The trials analyzed included 3,312 renal transplant recipients who were followed for a median of 12 months. The following subgroups were studied: elective calcineurin inhibitor sparing beyond 2 months after transplantation; calcineurin inhibitor sparing for transplant dysfunction; and de novo calcineurin inhibitor sparing.

        Calcineurin inhibitor sparing improved glomerular filtration rate significantly (weighted mean difference of 4.4 mL/min, P < .001), with evidence of improved graft survival (P = .06). Acute rejection rates were increased only following elective calcineurin inhibitor elimination (P < .001).

        There were no significant differences in mortality, malignancy, or incidence of infections.

        Dr. Wheatley concluded that calcineurin inhibitor-sparing strategies using adjunctive mycophenolate may play an important role in kidney transplant recipients, such as offering improvements in short-term graft function and possibly graft survival. He added that refinement of protocols for the elimination of calcineurin inhibitor may help to reduce the risk of rejection.

        [Presentation title: Kidney Transplantation and Calcineurin Inhibitor Sparing With Adjunctive Mycophenolate: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Abstract SA-PO2551]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send